Offer currently valued at $24.00 per CanniMed share. 56.9% premium to CanniMed closing price prior to Aurora's takeover proposal announcement. Lockup agreements already in place with shareholders holding 38% of CanniMed shares, including CanniMed's 3 largest shareholder
